FDA
Entity.
- Evidence
- 2,986 documents · 248 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 6 Apr 2026, last seen 2 Nov 2026
- Measured
- 35% of mentions say something specific about it; the rest only name it
- As of
- 2 Nov 2026
Where this comes from
- Tech Times · 2026-11-01 · FDA Clears Voceryq as First Plasmid DNA Immunotherapy for Recurrent Respiratory Papillomatosis (opens the source in a new tab)
- Tech Times · 2026-10-31 · FDA Approves Ilumya for Psoriatic Arthritis Treatment as Only Office-Administered IL-23 Inhibitor (opens the source in a new tab)
- STAT · 2026-10-30 · STAT+: FDA, CMS scramble to avoid regulatory logjam as more states look to test AI in clinical settings (opens the source in a new tab)
- Citybiz · 2026-10-30 · NRx Pharmaceuticals Wins FDA Approval for Preservative-Free Generic Ketamine Injection (opens the source in a new tab)
- an unnamed outlet · 2026-10-30 · INOVIO Announces FDA Accelerated Approval of VOCERYQ™, an Immunotherapy to Reduce the Frequency of Surgery in Adults with Recurrent Respiratory Papillomatosis (RRP) |… (opens the source in a new tab)
What is claimed about it
- Reported by two: Reported by two sources that did not copy each other.
- Single source: Reported by one source so far.
- Could not check: We could not count this claim's sources, so we do not say how well it is supported.
- FDA Approves First Plasmid DNA-based Immunotherapy for Adults with Recurrent Respiratory Papillomatosis Reported by two · first reported 30 Oct 2026
- STAT+: FDA, CMS scramble to avoid regulatory logjam as more states look to test AI in clinical settings Single source · first reported 30 Oct 2026
- Abbott’s paravalvular leak treatment secures FDA approval Single source · first reported 30 Oct 2026
- CereVasc Receives FDA IDE Approval to Evaluate the eShunt® System in Patients with Alzheimer's Disease Could not check · first reported 29 Oct 2026
- FDA Advisory No.2026-1681 || Public Health Warning Against the Purchase and Use of the Unregistered Medical Device Product “FIRST LINE FINGERTIP PULSE OXIMETER (YK-84C)” Single source · first reported 28 Oct 2026
- FDA Grants Breakthrough Device Designation to Pharaoh Neuro's Neurapheresis™ CSF Management System Single source · first reported 28 Oct 2026
- FDA Warning: Two Lots of Darwin’s Natural Pet Products Cat Food Test Positive for Salmonella Could not check · first reported 27 Oct 2026
- STAT+: FDA offers new details on quicker approval pathway for personalized gene therapies Single source · first reported 27 Oct 2026
Situations it is named in
- regulatory-approval-fdaa situation that names it